ADOCIA is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Approved therapeutic proteins Diabetes Insulin Formulation Drug delivery Fast Insulin Wound healing Diabetic Foot Ulcer Growth factors Cellular therapy Monoclonal antibodies mAbs Antibody-drug conjugate ADC Nanobodies Nanoparticle Oncology BioChaperone® Next-generation injectables for diabetes treatment Ultra-rapid Insulin Prandial Combinations Leverage approved hormones: insulin GLP-1 RA amylin glucagon Therapeutic proteins Multi-agents injectable combination Innovative protein formulation Metabolic diseases